alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Barry E. Greene
President and Chief Operating Officer, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 42 board members in 3 different organizations across 6 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Barry E. Greene has been the President and Chief Operating Officer at Alnylam Pharmaceuticals, Inc. since December 12, 2007 and October 2003 respectively. Mr. Greene has more than 20 years of experience in the healthcare, pharmaceutical and biotechnology industries. Mr. Greene joined Alnylam in 2003 and has over 15 years of experience in the healthcare industry. He served as the Principal Financial Officer and Principal Accounting Officer of Alnylam Pharmaceuticals ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*
Director, Chairman of Ad Hoc Business Development Committee and Member of Compensation Committee
Former Director and Member of Nominating & Corporate Governance Committee
Director, Chairman of Compensation Committee and Member of Audit Committee
University of Pittsburgh
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|J. Michael French||Chairman, Chief Executive Officer and President|
Marina Biotech, Inc.
|Peter French B.Sc, M.Sc, Ph.D., MBA||Chief Executive Officer, Managing Director and Director|
Benitec Biopharma Limited
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|$377.5K||Compensation as of Fiscal Year 2013.|